'김갑성' 기자의 전체기사
-
Flat Medical Honored at Premier, Inc.'s Annual Supplier Innov…
AUSTIN, Texas, July 16, 2025 -- FlatTech LLC, doing business as Flat Medical today announced that it was honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2025 Breakthroughs Conference and Exhibition. The Innovation Celebration recognizes groundbreaking healthcare technologies that have been launched throughout the year and the ways these products are helping to improve the health of communities. About the EpiFaith Smart Syringe The EpiFaith Smart Syringe transforms traditional epidural procedures by converting the tactile loss-of-resistance technique
- 김갑성 기자
- 2025-07-16 21:30
-
Rwazi Raises $12M to Replace Every Gut Call with an AI Copilot
In a world where delays cost millions, this AI copilot shows teams what's changing, what to do, and what happens next. LOS ANGELES, July 16, 2025 -- Rwazi has raised $12 million in Series A funding to replace every gut call with an AI copilot. The round will accelerate development of its simulation engine and decision copilot — giving teams real-time visibility into what's changing, what to do next, and what outcome to expect. "For decades, decisions have been driven by instinct. But gut calls are expensive — and in today's market, they're dangerous,"
- 김갑성 기자
- 2025-07-16 21:00
-
Rwazi, 1200만 달러 투자 유치 - 모든 직감적 결정을 AI 코파일럿으로 대체
지연이 수백만 달러의 손실로 이어지는 시대, 이 AI 코파일럿은 팀에게 무엇이 변하고 있는지, 무엇을 해야 하는지, 그리고 그 결과가 어떻게 될지를 실시간으로 보여준다. 로스앤젤레스, 2025년 7월 16일 -- Rwazi가 '감에 의존한 결정'을 대체하는 AI 코파일럿 개발을 위해 시리즈 A(Series A) 펀딩으로 미화 1200만 달러를 유치했다. 이번 투자금은 시뮬레이션 엔진 및 의사 결정 코파일럿 개발 가속화에 사용되며, 이를 통해 팀들이 실시간으로 변경 사항, 대응 전략, 예상 결과까지 가시화할 수 있도록 지원한다. 조셉 루타캉와 (Joseph Rutakangwa) Rwazi 공동 창업자 겸 최고경영자(CEO)는 "수십 년 동안 기업 의사결정은 '감'에 의존해 왔지만, 이런 결정은 비용이 많이 들고, 현재 시장 환경에서는 위험하기까지 하다"며 "이번 투자 유치를 통해 모든 의사결정자에게 실시간 AI 코파일럿을 제공함으로써, 팀이 더 빠르고 더 스마트하며 확신을 가지고 움직일 수 있게 만들 것"이라고 말했다. 대부분의 AI 시스템이 스크랩된
- 김갑성 기자
- 2025-07-16 21:00
-
SNB-101 Earns Government Backing as Promising Therapy for S…
SEONGNAM, South Korea, July 16, 2025 -- In a strong endorsement of its cutting-edge drug delivery technology, SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, a government-initiated program led by the Korea Drug Development Fund (KDDF). The program includes two years of research support, aiding the company's advancement of SNB-101 into global Phase 1b/2 trials. The Korea Drug Development Fund (KDDF) is a government agency funded by three ministries. It aims to actively fund and pro
- 김갑성 기자
- 2025-07-16 20:00
-
The 2025 Mammoth International Contest on Omics Sciences…
SHENZHEN, China, July 16, 2025 -- Under the guidance of UNESCO and the United Nations International Cooperation Public Welfare Organization, the 2025 Mammoth International Contest on Omics Sciences - Young Scientist Track (referred to as 2025 MICOS-Youth), co-organized by BGI Research and Jinze Charitable Foundation, was officially launched on May 22, 2025. About the Competition Previously, the Mammoth Cup had held four successful competitions with the focus on cutting-edge life science research and industry innovation. This year, the 5th edition of Mammoth Cup launched with a n
- 김갑성 기자
- 2025-07-16 18:12
-
Huawei Launches Global Education and Healthcare Partne…
SHENZHEN, China, July 16, 2025 -- Huawei held the 2025 Global Education and Healthcare Partner China Convention. Over 300 partner guests from 40 countries attended. At the event, Huawei launched the Global Education and Healthcare Partner Alliance (GEHPA). This initiative aims to strengthen communication with industry partners, leverage mutual strengths, achieve win-win cooperation, and ultimately build a high-quality, sustainable industry ecosystem. Members of the alliance can jointly undertake technical research and develop innovative solutions to power the digital transformation of educati
- 김갑성 기자
- 2025-07-16 18:05
-
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from…
[ 메디채널 김갑성 기자 ] Best ESG rating tier of negligible-risk with a top 1% global ranking score Industry and Regional ESG Top-Rated Company for five consecutive years Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, July 16, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has elevated its Morningstar Sustainalytics ESG rating score to the highest negligible-risk tier, demonstrating its leadership in the global pharmaceutical industry. Sustainalytics is a lea
- 김갑성 기자
- 2025-07-16 18:00
-
Huawei Launches Global Education and Healthcare Partne…
SHENZHEN, China, July 16, 2025 -- Huawei held the 2025 Global Education and Healthcare Partner China Convention. Over 300 partner guests from 40 countries attended. At the event, Huawei launched the Global Education and Healthcare Partner Alliance (GEHPA). This initiative aims to strengthen communication with industry partners, leverage mutual strengths, achieve win-win cooperation, and ultimately build a high-quality, sustainable industry ecosystem. Members of the alliance can jointly undertake technical research and develop innovative solutions to power the digital transformation of educati
- 김갑성 기자
- 2025-07-16 17:53
-
Syrian Girl, 8, Walks Overnight to Escape Shelling, Save the Child…
Photos: https://drive.google.com/drive/folders/1OIKkIC7kIPhFq-FWR7pO1-JbERqg29mN?usp=sharing HONG KONG, July 16, 2025 -- With shells drawing near and only minutes to escape, what would you save? "I was forced to leave everything behind – my toys, my clothes, all the things I loved," said 8-year-old Syrian girl Amal. In the harsh winter of 2024, she and her family walked for two days to flee the conflict, carrying nothing but the thin clothes on their backs. Food, water, shelter, and even a sense of security were all unwillingly left behind. A Tent for a Home
- 김갑성 기자
- 2025-07-16 17:04
-
ACTIVE 2.0 Project Launches in Malaysia to Improve Cervical C…
KUALA LUMPUR, Malaysia, July 16, 2025 -- A regional effort to improve cervical cancer care for patients has launched in Malaysia. Involving 6 countries in Southeast Asia, Project ACTIVE 2.0 aims to enhance cervical cancer treatment and support patient recovery across Southeast Asia. The three-year initiative will focus on strengthening healthcare systems through clinical training, infrastructure upgrades, and digital innovations, with the goal of expanding access to high-quality, targeted cervical cancer care for patients and their families. Cervical cancer remains a significan
- 김갑성 기자
- 2025-07-16 16:14
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-08-21_THU
2025-08-20_WED
- Global Times: Development opportunities, potential and advantages should be better used 23:58
- First IPO Under GIFT City's IFSC Regime - DRHP Filed; Executive Education Platform Leads the Charge 22:19
- Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning 22:14
- TGE alongside with AMTD Obtain Successful Court Decisions against Unauthorised and Infringing Activities in Austria 21:55
- Zylox-Tonbridge Announces 2025 Interim Results: Strong Revenue Growth with Net Profit Surging Over 76% Year-over-Year 21:41
- FOSSIL AND 2025-2026 GLOBAL BRAND AMBASSADOR NICK JONAS RELEASE EXCLUSIVE "MACHINE LUXE" CAPSULE 21:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 08월 21일 06시 40분